908 Devices Inc. (MASS): Shareholders' Equity
$143.70M
As of 2025-12-31
$126.77M
As of 2026-06-30
-9.0%
3-year compound annual growth
+0.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $143.70M | +25.4% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $114.59M | -30.8% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $165.49M | -13.2% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $190.60M | -11.2% | 2024-03-08, Balance as of period end |
| 2021-12-31 | $214.60M | +54.3% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $139.04M | n/a | 2022-03-11, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| 908 Devices Inc. (MASS) | 2025-12-31 | $143.70M | +25.4% |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $13.73M | -78.3% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | $33.21M | -55.9% |
| EyePoint, Inc. (EYPT) | 2025-12-31 | $306.11M | -9.0% |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | $44.42M | +25.6% |
| Precipio, Inc. (PRPO) | 2025-12-31 | $14.56M | +20.4% |
| Quanterix Corp (QTRX) | 2025-12-31 | $295.73M | -10.4% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $5.35M | -98.9% |
| Seer, Inc. (SEER) | 2025-12-31 | $259.31M | -20.8% |
Compare MASS, HBIO, RPID, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗